🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in individuals administering substances of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The company said it was committed to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

After moments of joining one community, a seller posted contact information, where most transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Item Details and Pricing

Inside these communities, posts show black plastic packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to possibly significant medical dangers”.